Time: 9:00 AM (PST), 12:00 PM (EST), 6:00 PM (CET)
Abstract
Discover the latest innovations in cervical cancer prevention and molecular diagnostics. This event will showcase cutting-edge advancements in integrated molecular automation and innovative assay design, with a specific focus on transforming screening practices through HPV self-collection in healthcare settings and extended genotyping designed to enhance risk assessment.
Learning Objectives:
Insightful Presentations: Learn from an industry leader about the impact of integrated molecular automation on laboratory efficiency and throughput.
Innovative Assay Design: Explore the capabilities of the BD Onclarity™ HPV Assay, the first FDA-approved test for extended genotyping, designed to provide comprehensive risk assessment.
Addressing Barriers: Understand how expanded HPV self-collection is improving screening access and patient engagement, reshaping cervical cancer screening paradigms.
Secure Your Spot:
Don't miss this opportunity to be at the forefront of transformative technologies driving the future of cervical cancer screening. Register now to join us as we shape the next era of healthcare together!
Webinars will be available for unlimited on-demand viewing after live event.
In recognition of Pancreatic Cancer Awareness Month, join us to explore how cutting-edge technologies are transforming our understanding of pancreatic ductal adenocarcinoma (PDAC), one of th...
Optimizing Quality Control Data Management in Molecular Infectious Disease Diagnostics Learning Objectives: Understand the regulatory complexities of quality control data management in diagn...
What happens when pharma and flow cores face the same challenge — doing more with less? Join Ryan Duggan (AbbVie) and David Leclerc (President, GLIIFCA) for a balanced discussion on h...
When it comes to Western blotting (WB), there is a wide range of different detection methods, reagents, and imaging systems used within scientific communities. But what approach can help ens...
Diabetes affects 589 million adults aged 20 – 79 years globally1. In honor of International Diabetes Day, join us for global webinar featuring a dynamic conversation about the role dia...
In today’s fast-paced and competitive biotechnology landscape, control and speed define success for companies and core labs producing synthetic genes. Yet many gene synthesis teams sti...
Loading Comments...
Please update your information
Certificate of Participation
Thank you for choosing Labroots. Please note that a Certificate of Participation does NOT count towards Continuing Education Credits.